| Sector Snap: Morgan Stanley on biotech drugmakers |
BusinessWeekA Morgan Stanley analyst said Friday that he believes shares of biotech drugmakers Gilead Sciences, Biogen Idec and Celgene will do well in 2012 because all three companies are poised to report encouraging results for important drug candidates.
|
| Investment Analysts' Ratings Reiterations for February, 10th (ALXN, ATVI, BIIB ... |
Web InquirerBiogen Idec Inc. (NASDAQ: BIIB) had its “neutral” rating re-affirmed by analysts at Zacks Investment Research. They now have a $124.00 price target on the stock. CBOE Holdings, Inc (NASDAQ: CBOE) had its “hold” rating re-affirmed by analysts at ...
|
| 5 Cheap Stocks To Consider Now |
Seeking AlphaBiogen Idec Inc. (BIIB) is a biotechnology company that spans therapeutics in neurology, immunology, and for cancers. Biogen Idec recently released its financial results for 2011 and expectations for 2012. The company reported a 7% increase in revenue ...
|
| Biogen Idec Shares Now Covered by Analysts at Morgan Stanley. (BIIB) |
Web InquirerInvestment analysts at Morgan Stanley (NYSE: MS) initiated coverage on shares of Biogen Idec (NASDAQ: BIIB) in a note issued to investors on Friday. They set an “overweight” rating on the stock. Separately, analysts at Zacks Investment Research ...
|
| ImmunoCellular (IMUC) Shareholder Update Validates Strong Potential for Growth |
BiotechStockTrader.com... of ImmunoCellular Therapeutics, Inc. (OTCBB:IMUC), a clinical stage biotechnology company targeting cancer stem cells by using the power of immunology and working in the same industry as Biogen Idec Inc. (NASDAQ:BIIB) and Amgen, Inc. (NASDAQ:AMGN).
|
| Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP ... |
24/7 Wall St.Biogen Idec Inc. (NASDAQ: BIIB) Started as Overweight at Morgan Stanley. Celgene Corporation (NASDAQ: CELG) Started as Overweight at Morgan Stanley. Coach, Inc. (NYSE: COH) Started as Buy at Citigroup. ConocoPhillips (NYSE: COP) Raised to Buy at ...
|
| Biogen Idec to Present at the Leerink Swann Global Healthcare Conference |
PharmiWeb.com (press release)Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Leerink Swann Global Healthcare Conference will be webcast live on Wednesday, February 15, 2012 at 8:30 am ET. To access the live webcast, please visit Biogen Idecā€™s ...
|
